Noosa News
Experts hail addition of two more vaccines to nation’s virus portfolio
Rather, Dr Griffin said, it boosted Australia’s “vaccine portfolio”.
“This gives us additional options and given they’re slightly different technologies they’re very complimentary to the two vaccines we already have an agreement for,” he said.
The vaccine candidates secured by Australia
Newly announced:
- Novavax- 40 million doses – currently in stage 2 and 3 clinical trials
- Pfizer- 10 million doses – currently in stage 2 and 3 clinical trials
Previously announced:
- UQ/CSL – 51 million doses – currently in an expanded stage 1 clinical trial
- University of Oxford/ AstraZeneca – 33.8 million doses – currently in stage 2 and 3 clinical trials
“Having an arrangement now for four vaccines gives us a better chance of having a vaccine…
Continue Reading
-
General13 hours agoTaylor Swift breaks Adele’s record for most album sales in first week
-
General18 hours agoMan charged with murder after alleged assault victim dies in Hervey Bay
-
Noosa News18 hours agoPublic health alert for nitazenes issued after person dies in Queensland
-
Business17 hours agoWhat’s Macquarie’s price target on Mineral Resources shares?